Showing posts with label Employment Discrimination. Show all posts
Showing posts with label Employment Discrimination. Show all posts

Wednesday, February 3, 2021

Disability Discrimination Claim Based Upon Plaintiff's Use of Medical Marijuana Rejected

  

In the case of Palmiter v. Commonwealth Health System, Inc., No. 20-CV-2544 (C.P. Lacka. Co. Nov. 10, 2020 Nealon, J.), an employment litigation based upon a claim of disability discrimination, the court ruled that, since the Plaintiff’s allegation that she was a patient who was authorized by the state to use medical marijuana for certain medical conditions failed to amount to an allegation that she had a “disability” under the Pennsylvania Human Relations Act, the Plaintiff was found unable to state a claim for employment discrimination in violation of the Act. 

As such, the court sustained the Preliminary Objections asserted by the defense. 

The court found that it was free and clear from any doubt, based upon the fact alleged in the Complaint, that the Plaintiff could not establish the requisite disability under the PHRA. As such, the Complaint was dismissed.

Anyone wishing to review a copy of this decision may click this LINK.

Source: “Digest of Recent Opinions.” Pennsylvania Law Weekly (Jan. 5, 2021).


UPDATE: Judge Nealon's decision was affirmed on appeal.  The appellate court opinion can be found at Palmiter v. Scranton Quincy Clinic Co., No. 498 MDA 2020 (Pa. Super. Aug. 10, 2021 Dubow, J., Bowes, J., Stevens, P.J.E.) (Op. by Bowes, J.).

In a case of first impression upon appeal, the Pennsylvania Superior Court ruled that an employee fired for their status as a certified medical marijuana user may sue for wrongful termination. The court noted that the Plaintiff could pursue a claim for wrongful discharge under the Medical Marijuana Act after her hospital employer discharged her for a positive drug test.

Anyone wishing to review a copy of this decision may click this LINK.

Tuesday, February 25, 2020

Wrongful Employment Discharge Claim Allowed to Proceed Under Medical Marijuana Act



In the case of Laidacker v. Berwick Offray, No. 726-CV-2019  (C.P. Col. Co. Jan. 2, 2020 James, J.), the court overruled Preliminary Objections to a Complaint that was filed on the basis of an alleged Medical Marijuana Act violation.

According to the Opinion, the Plaintiff sued after the Defendant revoked an offer of employment to the Plaintiff after the Plaintiff tested positive for marijuana.  However, the Plaintiff was a valid medical marijuana patient.

The Plaintiff sued the employer for a violation of the Medical Marijuana Act and under a claim of wrongful discharge.

The Medical Marijuana Act contains specific provisions that prohibit employers from discriminating against employees or prospective employees who are valid Medical Marijuana patients.

The defense raised the issue in its Preliminary Objections as to whether a plaintiff could sue for money damages under the Medical Marijuana Act where the Act only allegedly provided for administrative remedies.

Although Judge James noted in his decision that this issue appeared to be one of first impression, he also noted in footnote 2 of his Opinion that Judge Terrence R. Nealon of the Lackawanna County Court of Common Pleas had issued a similar decision in the case of Palmiter v. Commonwealth Health Systems.  The Tort Talk posts on the Palmiter case can be viewed HERE.

This decision appears to be the first one in which a Pennsylvania court has held that there is no conflict between the Medical Marijuana Act and federal law.

The decision is also noteworthy in that the court allowed punitive damages claim to proceed as well.

Anyone wishing to review this decision may click this LINK.


I send thanks to Attorney Matthew Mobilio of Mobilio Law in Allentown, PA for bringing this decision to my attention.

Thursday, February 6, 2020

Interlocutory Appeal Allowed in Case of Alleged Employment Discrimination For Medical Marijuana Use




Tort Talkers may recall the recent Tort Talk post regarding the case of Palmiter v. Commonwealth Health Systems, No. 19-CV-1315 (C.P. Lacka. Co. 2019 Nealon, J.), in which the court addressed the right of an employee to bring an action against her employer under allegations that the employer had improperly terminated the employee for being certified as a medical marijuana user by her treating doctor and discriminating against the employee on that basis.

Under a more recent December 31, 2019 decision in the same case, Judge Terrence R. Nealon, in this matter involving issues of first impression, allowed the Defendants to proceed with an interlocutory appeal.

This more recent decision is notable not only for the issues of first impression but also for the court’s review of the law surrounding the standards by which a trial court will review a request for permission to file an interlocutory appeal on a given issue.

Anyone wishing to review a copy of this decision may click this LINK.

Monday, December 23, 2019

Quoted in Nationally Published Article in Business Insurance Magazine on Civil Litigation Medical Marijuana Issue

Was quoted in this article in the nationally published Business Insurance magazine regarding the write-up on Judge Terrence R. Nealon's decision in the case of Palmiter v. Commonwealth Health Systems regarding the validity of a Plaintiff's employment discrimination lawsuit after she was fired for testing positive for marijuana use even though she advised the employer that she was an authorized user of medical marijuana:


Medical Marijuana Trend Means Growing Discrimination Exposures

by

Judy Greenwald

December 10, 2019


A growing number of workers and job applicants are successfully suing businesses for discrimination after they terminate or fail to hire them because of their medical marijuana use, experts say.

The trend is expected to accelerate with 33 states and the District of Columbia to date having legalized medical marijuana’s use, these experts say.

Recent cases include a Nov. 22 ruling by the Court of Common Pleas of Lackawanna County in Scranton, Pennsylvania, which became the first state or federal court in Pennsylvania to rule on the issue.

Complicating the situation for employers, meanwhile, is the fact that marijuana remains an illegal drug under federal law and various state laws create a patchwork quilt of legislation for them to follow.

Experts recommend that employers make an effort to engage in an interactive process with workers in states where medical marijuana has been legalized.

In the Pennsylvania case, the Court of Common Pleas held in Pamela Palmiter v. Commonwealth Health Systems Inc. at al. that although the state’s Medical Marijuana Act, which became effective in 2016, does not explicitly permit a private right of action by an employee who is allegedly discriminated against because of medical marijuana use, it does so implicitly.

“It opens the door to other lawsuits” and will be influential both inside the state and elsewhere, said Daniel E. Cummins, a partner with [Cummins Law] in Scranton that represents clients in civil litigation.

Observers point to comparable rulings in federal and state courts including in Arizona, Connecticut, Delaware, Massachusetts, New Jersey and Rhode Island.

Frederick T. Smith, a labor and employment attorney with Seyfarth Shaw LLP in Charlotte, North Carolina, said that of the 33 states that have legalized medical marijuana use, 16 provide workspace protections, either through their statutes or through case law interpreting their statutes, with the remaining either silent or ambiguous on the issue.

The 16 states are Arkansas, Arizona, Connecticut, Delaware, Illinois, Maine, Minnesota, Nevada, New Jersey, New Mexico, New York, Oklahoma, Pennsylvania, Rhode Island, West Virginia and Massachusetts.

Mr. Smith said that while courts initially tended to rule employees could not pursue discrimination charges in medical marijuana cases, “the tide started to turn in 2017, with decisions coming from courts in the Northeast that changed the risk analysis for the business community when it comes to applicants’ and employees’ use of marijuana.”

“There’s an increasing trend across all states to protect the medical use of marijuana and to treat it similarly to how prescription drugs are treated,” said Matthew A. Hesketh, a member of Sherman & Howard LLC in Phoenix, whose practice focuses on contractual disputes, corporate and business matters, administrative law and appellate litigation.

“If an employee would be entitled to use prescription drugs in compliance with the law, the trend is courts are willing to treat marijuana in the same way, assuming it has some recognized protection under state law,” he said.

“There are two primary avenues for recognizing protection of medical marijuana,” Mr. Hesketh said. “The first is through an antidiscrimination type of law, so generally, if medical marijuana can be viewed as a reasonable accommodation for someone’s disability, some states are willing to recognize that under their own state laws (that are) analogous to the (Americans With Disabilities Act), that the medical use of marijuana is potentially a reasonable accommodation,” although they cannot use it on the job site, he said.

The other source of protection is instances such as Arizona’s, where the law protects employers from taking any adverse action against an employee who is a registered medical marijuana cardholder as long as he does not come to work impaired.

“There’s going to be a movement” of litigation in this area, said Vance O. Knapp, a partner with Armstrong Teasdale LLP in Denver in management-side labor and employment law .

“The first step was to get it legalized,” he said. Now that its proponents have been successful, the next movement will be to provide protection for employees.

If workers have a medical marijuana card “the really smartest move to make” is to engage with them in an interactive process “and see if they have an underlying disability which requires accommodation,” said Amy Epstein Gluck, a partner with FisherBroyles LLP in Washington who advises business owners on compliance with anti-discrimination laws.

Mr. Smith said employers “should be reexamining their policies and practices and their tolerance for risk” in the 16 states that provide discrimination protection.

“Many companies are developing reasonable accommodation processes in order to determine whether applicants’ and employees’ use of medical marijuana doesn’t impact their ability to safely and effectively perform their jobs in the case of employees, and the jobs to which they are applying in the case of applicants,” he said.

Linda B. Hollinshead, a partner with Duane Morris LLP in Philadelphia, who provides training and counseling to employers, said she recommends employers look at the situation from the perspective of two points in time: at the prehiring, post-drug testing stage, and situations where the employee is already working at the company, where the issue most often arises post-accident and there is a reasonable suspicion of drug use.

In cases where the applicant has not yet been hired, employers should “carefully consider what kinds of positions they really want to be testing for,” and distinguish between safety-sensitive and nonsafety-sensitive positions, she said.

“I have many clients who have decided to not test for marijuana,” at least at the pre-hire stage, for nonsafety-sensitive positions, she added.

Employers who do conduct drug testing should work with their medical review officers and drug testing companies, and set up protocols that provide an expert’s independent judgment on the issue if the candidate tests positive, she said.

The employer should then engage in an interactive process with the applicant to determine if they can safely perform in the position for which they are being considered.

In cases where someone is already working at the company, employers “have to distinguish between safety-sensitive and nonsafety-sensitive” positions, but in states where medical marijuana has been legalized, the employer should not make a decision a worker should not be employed simply because they use medical marijuana, she said.

Experts recommend employers stay on top of local laws in this matter.

“Obviously this is an area of law that’s evolving rapidly,” said Mr. Hesketh. It is a lot to keep track of, he added, with new court cases, legislation and proposed legislation “almost every single day,” he said.

“The best advice I can give is to keep it on your radar” and be cognizant that “this is changing quickly. This isn’t something where you can just rely on old policies or handbooks or what may have been OK” even a year ago.

“It comes down to corporate culture and management decisions from one company to the next,” said Marshall Gilinsky, a shareholder with Anderson Kill P.C. in New York with practices in the firm’s insurance recovery and commercial litigation departments.

“You can see how there are reasons why, say, a trucking company might have a different policy compared to an advertising agency. But either way, it seems that when it comes to medical marijuana, the idea that someone can be fired because of the medicine that they’re taking doesn’t seem to be fair or make sense,” Mr. Gilinsky said.

“Obviously, if you have an employee who’s operating heavy equipment, it’s clear they can’t be intoxicated while on the job, but most medical marijuana products do not have intoxicating or hallucinatory effects.”

Federal action is also possible, said Paula A. Barran, founding partner at Barran Liebman LLP in Portland, Oregon, who represents management. “At some point, I think the patchwork quilt is going to force Congress to change where it’s headed,” she said.

Another factor to consider, she said, are remaining questions as to marijuana’s safety. “The products haven’t been studied for safety or purity or long-term effect,” she said.

Monday, December 2, 2019

Case of First Impression Decided by Judge Nealon on Medical Marijuana Issue in Civil Litigation Context



Addressing a case of first impression in the case of Palmiter v. Commonwealth Health Systems, Inc., No. 19-CV-1315 (C.P. Lacka. Co. Nov. 22, 2019 Nealon, J.), Judge Terrence R. Nealon reviewed Preliminary Objections filed by employers in this employment litigation raising a novel issue that has not yet been addressed by any state or federal court in Pennsylvania, that being the question of whether §2103(b)(1) of the Medical Marijuana Act (“MMA”), 35 Pa. S. §10231.2103(b)(1), which states that “[n]o employer may discharge… or otherwise discriminate or retaliate against an employee…solely on the basis of such employee’s status of an individual who is certified to use medical marijuana” creates a private cause of action for a medical assistant who was terminated by her health care employers for prescribed use of medical marijuana while not working in her place of employment.

The Defendants noted that the Department of Health has the exclusive authority to enforce the MMA’s provisions such that the employee’s sole remedy for her termination should be to seek the assessment of a civil penalty by the Department of Health.

After his review of the law, Judge Nealon held that there was nothing the MMA or any related regulations that vests the Department of Health, or any other state agency, with the authority to enforce the Act against private employers that have not chosen to voluntarily take part in the program.

The court also noted that the anti-discrimination provisions in the act would be rendered meaningless if an aggrieved employee could not pursue a private cause of action and seek to recover compensatory damages from an employer that violates the MMA.

As such, the court recognized an implied right of action under the act and, therefore, denied the employers’ demurrer to the employee’s private cause of action based upon §2103(b)(1).

In other decisions of note in this case, Judge Nealon did sustain demurrers to claims for invasion of privacy/intrusion on seclusion based upon the employee’s contention that her employers discovered the identity of her treating physician from their review of her medical records.

Anyone wishing to review a copy of this decision may click this LINK.